SARS-COV-2
Clinical trials for SARS-COV-2 explained in plain language.
Never miss a new study
Get alerted when new SARS-COV-2 trials appear
Sign up with your email to follow new studies for SARS-COV-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Moderna infant COVID vaccine trial halted early
⭐️ VACCINE ⭐️ TerminatedThis study aimed to test the safety and effectiveness of Moderna's updated COVID-19 vaccine (mRNA-1273.214) in very young infants, aged 12 weeks to under 6 months. It planned to compare the babies' immune responses to those seen in adults from a previous study. However, the trial…
Matched conditions: SARS-COV-2
Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 16, 2026 15:23 UTC
-
Early-Stop trial tests antibody cocktail for mild COVID cases
Disease control TerminatedThis study aimed to test the safety and effectiveness of a new antibody drug combination (REGN14256+Imdevimab) for treating COVID-19 in people who were otherwise healthy and at low risk of severe illness. The trial enrolled adults and planned to include adolescents to see if the …
Matched conditions: SARS-COV-2
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Apr 04, 2026 04:51 UTC
-
Could a daily pill shield frontline workers from COVID?
Prevention TerminatedThis study tested whether a daily pill (Emtricitabine/Tenofovir) could prevent COVID-19 in healthcare workers at high risk of exposure. Over 1,300 participants were randomly assigned to receive either the pill or a placebo, in addition to standard safety measures like masks. The …
Matched conditions: SARS-COV-2
Phase: PHASE3 • Sponsor: Hospital Italiano de Buenos Aires • Aim: Prevention
Last updated Mar 23, 2026 15:15 UTC